Influence of isoprostane F2α-III on reflow after myocardial infarction

European Heart Journal

Volumn 25, Issue 10, 2004, Pages 847-853

  Greaves, Kim ^a   Dixon, Simon R ^b   Coker, Ivan O'Brien ^c   Mallet, Anthony I ^c   Avkiran, Metin ^a   Shattock, Michael J ^a   Fejka, Martin J ^b   O'Neill, William W ^b   Senior, Roxy ^d   Redwood, Simon ^a   Marber, Michael S ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b WILLIAM BEAUMONT HOSPITAL   (United States)

^c UNIVERSITY OF GREENWICH   (United Kingdom)

^d NORTHWICK PARK HOSPITAL   (United Kingdom)

Author keywords

Isoprostanes; Myocardial infarction; Reperfusion

Indexed keywords

7 [3 [(4 PHENYLSEMICARBAZIDO)METHYL] 7 OXABICYCLO[2.2.1]HEPT 2 YL] 5 HEPTENOIC ACID; ISOPROSTANE DERIVATIVE; ISOPROSTANE F2 ALPHA III; UNCLASSIFIED DRUG; ISOPROSTANE F2ALPHA III; VASODILATOR AGENT;

ACUTE HEART INFARCTION; ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL REACTIVITY; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY CONSTRICTION; CORONARY STENT; FEMALE; HEART INFARCTION SIZE; HUMAN; ISOLATED HEART; MALE; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN BLOOD LEVEL; TRANSLUMINAL CORONARY ANGIOPLASTY; ANIMAL; BLOOD; CLINICAL TRIAL; HEART INFARCTION; HEART MUSCLE REPERFUSION; METABOLISM; METHODOLOGY; MOUSE; MULTICENTER STUDY; PATHOLOGY; PHYSIOLOGY; PROSPECTIVE STUDY;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANIMALS; CORONARY CIRCULATION; FEMALE; HUMANS; ISOPROSTANES; MALE; MICE; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; PROSPECTIVE STUDIES; VASODILATOR AGENTS;

EID: 4444302808     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ehj.2004.03.015     Document Type: Article

References (34)

1. Simes RJ, Topol EJ, Homes Jr DR et al. Link between the angiographic substudy and mortality outcomes in a large randomized trial of myocardial reperfusion. Importance of early and complete infarct artery reperfusion. GUSTO-I Investigators. Circulation 1995;91:1923-8.
2. Maes A, Van der Werf F, Nuyts J et al. Impaired myocardial tissue perfusion early after successful thrombolysis. Impact on myocardial flow, metabolism, and function at late follow-up. Circulation 1995;92:2072-8.
3. Ito H, Tomooka T, Sakai N et al. Lack of myocardial perfusion immediately after successful thrombolysis. A predictor of poor recovery of left ventricular function in anterior myocardial infarction. Circulation 1992;85:1699-705.
4. Rezkalla SH, Kloner RA. No-reflow phenomenon. Circulation 2002;105:656-62.
5. Pratico D. F(2)-isoprostanes: sensitive and specific non-invasive indices of lipid peroxidation in vivo. Atherosclerosis 1999;147:1-10.
6. Li H, Lawson JA, Reilly M et al. Quantitative high performance liquid chromatography/tandem mass spectrometric analysis of the four classes of F(2)-isoprostanes in human urine. Proc Natl Acad Sci USA 1999;96:13381-6.
7. Cracowski JL, Durand T, Bessard G. Isoprostanes as a biomarker of lipid peroxidation in humans: physiology, pharmacology and clinical implications. TIPS 2002;23:360-6.
8. Marliere S, Cracowski JL, Durand T et al. The 5-series F2-isoprostanes possess no vasomotor effects in the rat aorta, the human internal mammary artery and the human saphenous vein. Br J Pharmacol 2002;135:1276-80.
9. Delanty N, Reilly MP, Pratico D et al. 8-epi PGF2 alpha generation during coronary reperfusion. A potential quantitative marker of oxidant stress in vivo. Circulation 1997;95:2492-9.
10. Kromer BM, Kaski JC, Murdday A et al. Evidence for a role for the isoprostane 8-epi-prostaglandin F2a in ischaemic heart disease. Br J Clin Pharmacol 1998;45:197P-8P.
11. Kijima Y, Hashimura K, Matsu-ura Y et al. Transcardiac 8-isoprostaglandin F (2 alpha) generation from acute myocardial infarction heart: insight into abrupt reperfusion and oxidant stress. Prostaglandins Leukot Essent Fatty Acids 2001;64:161-6.
12. Mobert J, Becker BF, Zahler S et al. Hemodynamic effects of isoprostanes (8-iso-prostaglandin F2alpha and E2) in isolated guinea pig hearts. J Cardiovasc Pharmacol 1997;29:789-94.
13. Kromer BM, Tippins JR. Coronary artery constriction by the isoprostane 8-epi prostaglandin F2 alpha. Br J Pharmacol 1996;119:1276-80.
14. Iuliano L, Pratico D, Greco C et al. Angioplasty increases coronary sinus F2-isoprostane formation: evidence for in vivo oxidative stress during PTCA. J Am Coll Cardiol 2001;37:76-80.
15. Cracowski JL, Marliere S, Bessard G. Vasomotor effects and pathophysiologic relevance of F(2)-isoprostane formation in vascular diseases. J Am Coll Cardiol 2002;39:554-5.
16. Gopaul NK, Anggard EE, Mallet AI et al. Plasma 8-epi-PGF2 alpha levels are elevated in individuals with non-insulin dependent diabetes mellitus. FEBS Lett 1995;368:225-9.
17. Walter MF, Blumberg JB, Dolnikowski GG et al. Streamlined F2-isoprostane analysis in plasma and urine with high- performance liquid chromatography and gas chromatography/mass spectroscopy. Anal Biochem 2000;280:73-9.
18. Gibson CM, Cannon CP, Daley WL et al. TIMI frame count: a quantitative method of assessing coronary artery flow. Circulation 1996;93:879-88.
19. Van't Hof AW, Liem A, Suryapranata H et al. Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial blush grade. Zwolle Myocardial Infarction Study Group. Circulation 1998;97:2302-6.
20. Saurin AT, Pennington DJ, Raat NJH et al. Targeted disruption of the protein kinase C epsilon gene abolishes the infarct size reduction that follows ischaemic preconditioning of isolated buffer-perfused mouse hearts. Cardiovasc Res 2002;55:672-80.
21. Ito H, Taniyama Y, Iwakura K et al. Intravenous nicorandil can preserve microvascular integrity and myocardial viability in patients with reperfused anterior wall myocardial infarction. J Am Coll Cardiol 1999;33:654-60.
22. Taniyama Y, Ito H, Iwakura K et al. Beneficial effect of intracoronary verapamil on microvascular and myocardial salvage in patients with acute myocardial infarction. J Am Coll Cardiol 1997;30:1193-9.
23. Cipollone F, Ciabattoni G, Patrignani P et al. Oxidant stress and aspirin-insensitive thromboxane biosynthesis in severe unstable angina. Circulation 2000;102:1007-13.
24. Reilly MP, Delanty N, Roy L et al. Increased formation of the isoprostanes IPF2alpha-I and 8-epi- prostaglandin F2alpha in acute coronary angioplasty: evidence for oxidant stress during coronary reperfusion in humans. Circulation 1997;96:3314-20.
25. Lawson JA, Rokach J, FitzGerald GA. Isoprostanes: formation, analysis and use as indices of lipid peroxidation in vivo. J Biol Chem 1999;274:24441-4.
26. Bessard J, Cracowski JL, Stanke-Labesque F et al. Determination of isoprostaglandin F2alpha type III in human urine by gas chromatography-electronic impact mass spectrometry. Comparison with enzyme immunoassay. J Chromatogr B Biomed Sci Appl 2001;754:333-43.
27. Proudfoot J, Barden A, Mori TA et al. Measurement of urinary F(2)-isoprostanes as markers of in vivo lipid peroxidation-A comparison of enzyme immunoassay with gas chromatography/mass spectrometry. Anal Biochem 1999;272:209-15.
28. Pratico D, Smyth EM, Violi F et al. Local amplification of platelet function by 8-epi prostaglandin F2alpha is not mediated by thromboxane receptor isoforms. J Biol Chem 1996;271:14916-24.
29. Kinsella BT, O'Mahony DJ, FitzGerald GA. The human thromboxane A2 receptor alpha isoform (TP alpha) functionally couples to the G proteins Gq and G11 in vivo and is activated by the isoprostane 8-epi prostaglandin F2 alpha. J Pharmacol Exp Ther 1997;281:957-64.
30. Pratico D, Iuliano L, Mauriello A et al. Localization of distinct F2-isoprostanes in human atherosclerotic lesions. J Clin Invest 1997;100(8):2028-34.
31. Audoly LP, Rocca B, Fabre JE et al. Cardiovascular responses to the isoprostanes iPF (2alpha)-III and iPE(2)-III are mediated via the thromboxane A(2) receptor in vivo. Circulation 2000;101:2833-40.
32. McCord JM. Free radicals and myocardial ischaemia: an overview and outlook. Free Radic Biol Med 2002;4:9-14.
33. Grech ED, Dodd NJ, Jackson MJ et al. Evidence for free radical generation after primary percutaneous transluminal coronary angioplasty recanalization in acute myocardial infarction. Am J Cardiol 1996;77:122-7.
34. Grech ED, Dodd NJ, Bellamy CM et al. Free-radical generation during angioplasty reperfusion for acute myocardial infarction. Lancet 1993;341:990-1.